Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Dylan Berman

Cidara Shares Are Trading Higher Friday: What's Going On?

Medical researcher

Cidara Therapeutics, Inc. (NASDAQ:CDTX) shares are trading higher Friday after the company secured $339 million in BARDA funding to advance its CD388 pandemic influenza therapeutic and onshore its manufacturing.

What To Know: The agreement includes $58 million in base funding over 24 months to support the onshoring of CD388 manufacturing in the United States, conduct a clinical trial to compare higher-concentration formulations, test different presentations, further evaluate activity in non-clinical models and begin developing protocols for expanded populations.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.